Detection and characterization of circulating tumor associated cells in metastatic breast cancer

Zhaomei Mu*, Naoual Benali-Furet, Georges Uzan, Anaëlle Znaty, Zhong Ye, Carmela Paolillo, Chun Wang, Laura Austin, Giovanna Rossi, Paolo Fortina, Hushan Yang, Massimo Cristofanilli

*Corresponding author for this work

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

The availability of blood-based diagnostic testing using a non-invasive technique holds promise for real-time monitoring of disease progression and treatment selection. Circulating tumor cells (CTCs) have been used as a prognostic biomarker for the metastatic breast cancer (MBC). The molecular characterization of CTCs is fundamental to the phenotypic identification of malignant cells and description of the relevant genetic alterations that may change according to disease progression and therapy resistance. However, the molecular characterization of CTCs remains a challenge because of the rarity and heterogeneity of CTCs and technological difficulties in the enrichment, isolation and molecular characterization of CTCs. In this pilot study, we evaluated circulating tumor associated cells in one blood draw by size exclusion technology and cytological analysis. Among 30 prospectively enrolled MBC patients, CTCs, circulating tumor cell clusters (CTC clusters), CTCs of epithelial-mesenchymal transition (EMT) and cancer associated macrophage-like cells (CAMLs) were detected and analyzed. For molecular characterization of CTCs, size-exclusion method for CTC enrichment was tested in combination with DEPArray™ technology, which allows the recovery of single CTCs or pools of CTCs as a pure CTC sample for mutation analysis. Genomic mutations of TP53 and ESR1 were analyzed by targeted sequencing on isolated 7 CTCs from a patient with MBC. The results of genomic analysis showed heterozygous TP53 R248W mutation from one single CTC and pools of three CTCs, and homozygous TP53 R248W mutation from one single CTC and pools of two CTCs. Wild-type ESR1 was detected in the same isolated CTCs. The results of this study reveal that size-exclusion method can be used to enrich and identify circulating tumor associated cells, and enriched CTCs were characterized for genetic alterations in MBC patients, respectively.

Original languageEnglish (US)
Article number1665
JournalInternational journal of molecular sciences
Volume17
Issue number10
DOIs
StatePublished - Oct 1 2016

Keywords

  • Cancer associated macrophage-like cells (CAMLs)
  • Circulating tumor associated cells
  • Circulating tumor cell clusters (CTC clusters)
  • Circulating tumor cells (CTCs)
  • Epithelial-mesenchymal transition (EMT)
  • Metastatic breast cancer (MBC)
  • Size-exclusion technology

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Fingerprint Dive into the research topics of 'Detection and characterization of circulating tumor associated cells in metastatic breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Mu, Z., Benali-Furet, N., Uzan, G., Znaty, A., Ye, Z., Paolillo, C., Wang, C., Austin, L., Rossi, G., Fortina, P., Yang, H., & Cristofanilli, M. (2016). Detection and characterization of circulating tumor associated cells in metastatic breast cancer. International journal of molecular sciences, 17(10), [1665]. https://doi.org/10.3390/ijms17101665